Skip to main content
. 2018 Sep 1;10(1):e2018049. doi: 10.4084/MJHID.2018.049

Figure A1.

Figure A1

Comparison of LIC in patients with Sickle Cell Disease who had received chelation therapy for 12 months revealed significant improvement (lic1: pre-treatment, lic2: end of study).